Table 2.
Demographics and clinical characteristics of the patients.
| n = 82 | |
|---|---|
| Age (years/mean ± SD / min–max) | 6.34 ± 3.55 (3–15) |
| ASA, n (%) | |
| I | 26 (31.7%) |
| II | 56 (68.3%) |
| LMA size, n (%) | |
| no = 2 | 24 (29.3%) |
| no = 2.5 | 30 (36.6%) |
| no = 3 | 28 (34.1%) |
| Placement of LMAs, n (%) | |
| NRS = 0 | 40 (48.8%) |
| NRS = 1 | 7 (8.5%) |
| NRS = 2 | 10 (12.2%) |
| NRS = 3 | 10 (12.2%) |
| NRS = 4 | 7 (8.5%) |
| NRS = 5 | 4 (4.9%) |
| NRS = 7 | 2 (2.4%) |
| NRS = 8 | 2 (2.4%) |
| Propofol (mg) | 80.49 ± 56.78 |
| Remifentanil (µg) | 51.80 ± 29.42 |
ASA, American Society of Anesthesiologists physical status; LMA, Laryngeal Mask Airway; NRS, Numeric Rating Scale.